16th Annual CHFR Symposium on Heart Failure

September 19-21 2018 at Holmenkollen Park Hotel, Oslo, Norway.

- Wednesday 19th: NORHEART Cardiac Café - the place to meet and be inspired! Lecture by Valentin Fuster, Editor in Chief of JACC, Icahn School of Mecdicine at Mount Sinai, New York, USA

- Thursday 20th: Day 1 of main program with Key Note Lecture and moderated poster sessions

- Friday 21st: Day 2 of main program with presentation by poster price winners

Click for more information and registration...

Confirmed speakers:

Valentin Fuster, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Nick L Mills, King's College London BHF Centre, The Rayne Institute, St Thomas' Hospital, London, UK
Satoshi Nakatani, Osaka University Graduate School of Medicine, Suita, Japan
Manuel Mayr, King's College, University of London, London, UK
Denise Hilfiker-Kleiner, Hannover Medical School, Hannover, Germany
Jagat Narula, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Thomas H Marwick, Baker Heart and Diabetes Institute, Melbourne, Australia
David A Kass, Institute for CardioScience, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
Xander HT Wehrens, Baylor College of Medicine, Houston, Tx, USA
Brendan M Everett, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Douglas L Mann, Washington University School of Medicine, St. Louis, MO, USA
Sanjay Sharma, St. Georges University of London, London, United Kingdom

Scientific Reports 7

Hot Topics: Circulating levels of CCN2 in the acute phase of STEMI are not associated with final infarct size, LV function or new clinical events

Although a possible cardioprotective role of CCN2/CTGF following myocardial infarction has been suggested, no significant associations between levels of CCN2 and infarct size, LV remodelling and function and new clinical events including mortality were found.

Read more in Scientific Reports 7, Article number: 11945 (2017)


Hot Topics: Beta-blockers improve EF and prognosis for patients with HFrEF and HFmrEF but not with HFpEF

A meta-analysis of 11 trials demonstrated that beta-blockers reduce all-cause and cardiovascular mortality and increase EF in patients in sinus rhythm with EF < 50%. For patients in atrial fibrillation, beta-blockers increased EF when < 50% at baseline, but did not improve prognosis.

Read more in European Heart Journal

Cell Reports, Volume 18, Issue 1

Hot Topics: NEIL3-dependent regulation of cardiac fibroblast proliferation prevents myocardial rupture

Neil3-/- mice show increased mortality after myocardial infarction caused by myocardial rupture. Neil3-/- ruptured hearts show increased proliferation of fibroblasts and myofibroblasts.

Read more in Cell Reports, Volume 18, Issue 1

Journal of the American College of Cardiology

Hot Topics: Echocardiographic assessment of LV filling pressure is feasible and accurate

In a multicenter study of 450 patients using invasively measured LV pressure as the gold standard, echocardiography had an accuracy of 87% of identifying patients with elevated LV filling pressure.

Read more in Journal of the American College of Cardiology, Volume 69, Issue 15

Journal of the American College of Cardiology 70

Hot Topics: Due to geometric confounders, strain better reflects systolic function in patients with preserved EF

Using an analytical equation showing the relationship between EF and global longitudinal and circumferential strain, wall thickness, and short-axis diameter, it was found that reduced deformation despite preserved EF can be explained through geometric factors.

Read more in Journal of the American College of Cardiology, Volume 70, Issue 8


Prize winners of the Poster Session CHFR 2017

The 15th Annual CHFR Symposium took place at Holmenkollen Park Hotel, Oslo. More than 70 poster presenters contributed with recent advances in basic and clinical heart research.

Click to see the Prize winners of the Poster Session

Click to see other pictures from the Annual CHFR Symposium 2017

Click to see pictures from The Cardiac Café

Click to see more pictures from the Moderated poster sessions

Thank you to all participants, and invited Speakers:
Key note by Calum A. MacRae, Brigham and Women’s Hospital and Harvard Medical School. Other speakers:
Anthony Rosenzweig, Harvard Medical School, USA.
Burkert Pieske, Charité Universitätsmedizin Berlin and Deutsches Herzzentrum Berlin.
Carolyn Lam, National Heart Centre Singapore.
Dan Roden, Vanderbilt University Medical Center, USA.
James L Januzzi, Massachusetts General Hospital and Harvard Research Clinical Institute, USA.
Julia Gorelik, Imperial College London, UK.
Leon Axel, NYU Langhorne Medical Center, USA
Ole M. Sejersted, University of Oslo and Oslo University Hospital
Peter Libby, Brigham and Women's Hospital, Harvard Med. School, USA.
Stefan Engelhardt, Technische Universität München.
Sumanth D. Prabhu, University of Alabama, USA.

QuoteIllustrasjon forside

Webmaster Vidar, IEMF